ACSL4: Activation of long-chain fatty acids for both synthesis of cellular lipids, and degradation via beta-oxidation. Preferentially uses arachidonate and eicosapentaenoate as substrates. Defects in ACSL4 are the cause of mental retardation X- linked type 63 (MRX63). Mental retardation is a mental disorder characterized by significantly sub-average general intellectual functioning associated with impairments in adaptative behavior and manifested during the developmental period. Non- syndromic mental retardation patients do not manifest other clinical signs. Defects in ACSL4 are involved in Alport syndrome with mental retardation midface hypoplasia and elliptocytosis (ATS-MR). A X-linked contiguous gene deletion syndrome characterized by glomerulonephritis, deafness, mental retardation, midface hypoplasia and elliptocytosis. Belongs to the ATP-dependent AMP-binding enzyme family. 2 isoforms of the human protein are produced by alternative splicing.
Protein type: Lipid Metabolism - fatty acid; EC 6.2.1.3; Membrane protein, integral; Ligase
Chromosomal Location of Human Ortholog: Xq22.3-q23
Cellular Component: cell soma; cytoplasm; endoplasmic reticulum membrane; integral to membrane; lipid particle; membrane; mitochondrial outer membrane; peroxisomal membrane
Molecular Function: arachidonate-CoA ligase activity; ATP binding; long-chain-fatty-acid-CoA ligase activity; very-long-chain-fatty-acid-CoA ligase activity
Biological Process: cellular lipid metabolic process; embryonic process involved in female pregnancy; fatty acid transport; lipid biosynthetic process; lipid metabolic process; long-chain fatty acid metabolic process; negative regulation of prostaglandin secretion; positive regulation of cell growth; response to nutrient; triacylglycerol biosynthetic process
Disease: Mental Retardation, X-linked 63
Show more